Skip to main content
Log in

Expression ofHer2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma

  • Original Papers
  • Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

The expression of theHer2/neu gene product p 185 was retrospectively analyzed in 58 patients with gastric carcinoma. The results were correlated to various clinicopathological and prognostic factors. Positive membrane staining for p185 could be detected in 38% of the patients (22/58). Membrane staining was significantly greater in well and moderately differentiated tumors of the intestinal type when compared with poorly differentiated lesions and carcinomas of the diffuse type (P<0.01). Positive membrane staining did not correlate with site and tumor stage, but T1 lesions had less membrane staining than more advanced primary tumors. Overall survival showed no difference between p185-positive and negative cases. Multivariate analysis defined a subgroup of curatively resected patients with stage III and IV disease that had a statistically significant poorer survival when p185 was overexpressed (P=0.005). Overexpression of theHer2/neu product p185 appears to be associated with intestinal-type gastric carcinoma and may sociated with intestinal-type gastric carcinoma and may help in identifying a subset of patients at increased risk for shorter survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

PBS:

phosphate-buffered saline

BSA:

bovine serum albumin

References

  • Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T (1986) The product of the human c-er B-2 gene: a 185-kilodalton glycoprotein with typrosine kinase activity. Science 232:1644–1646

    Google Scholar 

  • Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE (1988) Corrleation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48:1238–1243

    Google Scholar 

  • Clark GM, McGuire WL (1991) Follow-up study ofHer2/neu amplification in primary breast cancer. Cancer Res 51:944–948

    Google Scholar 

  • Di Fiore PP, Pierce JH, Kraus MH, Segatto O, Richter King C, Aaronson SA (1987).ErbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237:178–182

    Google Scholar 

  • Falck VG, Gullick WJ (1989) c-erb B-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study. J Pathol 159:107–111

    Google Scholar 

  • Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767

    Google Scholar 

  • Fukushige SI, Matsubara KI, Yoshida M, Sasaki M, Suzuki T, Semba K, Toyoshima K, Yamamoto T (1986) Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol Cell Biol 6:955–958

    Google Scholar 

  • Gutman M, Ravia Y, Assaf D, Yamamoto T, Rozin R, Shiloh Y (1989) Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance. Int J Cancer 44:802–805

    Google Scholar 

  • Houldsworth J, Cordon-Cardo C, Ladanyi M, Kelsen DP, Chaganti RSK (1990) Gene amplification in gastric and esophageal adenocarcinoma. Cancer Res 50:6417–6422

    Google Scholar 

  • Hsu SM, Raine L, Fauger H (1981) Comparative study of the peroxidase-antiperoxidase and avidin-biotin complex method for studying polypeptide hormones with radioiummunoassay antibodies. Am J Pathol 75:734–740

    Google Scholar 

  • Jaehne J, Meyer HJ, Maschek H, Geerlings H, Bruns E, Pichlmayr R (1992) Lymphadenectomy in gastric carcinoma—a prospective and prognostic study. Arch Surg 127:290–294

    Google Scholar 

  • Kameda T, Yashi W, Yoshida K, Tsujino T, Nakayama H, Ito M, Ito H, Tahara E (1990) Expression of ERBB2 in human gastric carcinomas: relationsship between p185ERBB2 expression and the gene amplification. Cancer Res 50:8002–8009

    Google Scholar 

  • Laurén P (1965) The two histolocial main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31–49

    Google Scholar 

  • Lundegardh G, Asami HO, Malker B (1986) Gastric cancer survival in Sweden. Ann Surg 204:546–551

    Google Scholar 

  • Lupu R, Colomer R, Zugmeier G, Sarup J, Shepard M, Slamon D, Lippman ME (1990) Direct interaction of a ligand for theerbB2 oncogene product with the EGF receptor and p185erbB2. Science 249:1552–1555

    Google Scholar 

  • Masood S, Barker EA, Barnes RE (1991)Her2/neu oncogene protein and prognosis in gastric adenocarcinoma. Mod Pathol 4:38A

    Google Scholar 

  • Nanus DM, Kelsen DP, Niedzwiecki D, Chapman D, Brennan M, Cheng E, Melamed M (1989) Flow cytometry as a predictive indicator in patients with operable gastric cancer. J Clin Oncol 7:1105–1112

    Google Scholar 

  • Oda N, Tsujino T, Tsuda T, Yoshida K, Nakayama H, Yasui W, Tahara E (1990) DNA ploidy pattern and amplification of ERBB and ERBB2 genes in human gastric carcinomas. Virchows Arch [B] 58:273–277

    Google Scholar 

  • Oota K, Sobin LH (1977) Histological typing of gastric and oesophageal tumors. International histological classification of tumors. WHO, Geneva, no. 18

    Google Scholar 

  • Ovaska J, Kruuna I, Saario I, Schröder T, Lempinen M (1989) Surgical treatment of gastric carcinoma. Am J Surg 158:467–471

    Google Scholar 

  • Pavelic ZP, Petrelli NJ, Herrera L, Vaugham MM, Paecock JS, Pavelic L (1990) D-14 monoclonal antibody to carcinoembryonic antigen: immunohistochemical analysis of formalinfixed, paraffin-embedded human colorectal carcinoma, tumors of non-colorectal origin and normal tissues. J Cancer Res Clin Oncol 116:51–56

    Google Scholar 

  • Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, Weinberg RA (1984) Theneu oncogene: anerb-B-related gene encoding a 185,00-Mr tumor antigen. Nature 312:513–516

    Google Scholar 

  • Shiu MH, Moore E, Sanders M, Huvos A, Freedman B, Goodbold J, Chaiyaphruk S, Wesdorp R, Brennan MF (1987) Influence of the extent of resection on survial after curative treatment of gastric carcinoma. Arch Surg 122:1347–1351

    Google Scholar 

  • Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of theHer2/neu oncogene. Science 235:177–182

    Google Scholar 

  • Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989a) Stdies of theHer2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712

    Google Scholar 

  • Slamon DJ, Press MF, Godolphin W, Ramos L, Haran P, Shek L, Stuart SG, Ullrich A (1989b) Studies of theHer2/neu oncogene in human breast cancer. Cancer Cells 7:371–384

    Google Scholar 

  • Tal M, Wetzler M, Josefberg Z, Gutman M, Assaf D, Kris R, Shiloh Y, Givol D, Schlessinger J (1988) Sporadic amplification of theHer2/neu protooncogene in adenocarcinomas of various tissues. Cancer Res 48:1517–1520

    Google Scholar 

  • UICC (1987) TNM classification of malignant tumors, 4th edn. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R (1988). Neu-protein overexpression in breast cancer. N Engl J Med 319:1239–1245

    Google Scholar 

  • Wilke H, Preusser P, Fink U, Achterrath W, Meyer HJ, Stahl M, Lanz L, Meyer J, Siewert JR, Geerlings H, Köhne-Wömpner CH, Harstrick A, Schmoll HJ (1990) New developments in the treatment of gastric carcinoma. Semin Oncol 17:61–70

    Google Scholar 

  • Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K (1986) Similarity of protein encoded by human c-erbB-2 gene to epidermal growth factor receptor-related protein. Nature 319:230–234

    Google Scholar 

  • Yokota J, Yamamoto T, Toyoshima K, Terada M, Sugimura T, Battifora H, Cline MJ (1986) Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet 1:765–767

    Google Scholar 

  • Yokota J, Yamamoto T, Miyajima N, Toyoshima K, Nomura N, Sakamoto H, Yoshida T, Terada M, Sugimura T (1988) Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erb A homologue. Oncogene 2:283–287

    Google Scholar 

  • Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka M, Sasaki T (1991a) Evaluation of immunoreactivity forerbB-2 protein as a maker of poor short term prognosis in gastric cancer. Cancer Res 51:1034–1038

    Google Scholar 

  • Yonemura Y, Ninomiya I, Ohoyama S, Kimura H, Yamaguchi A, Fushida S, Kosaka T, Miwa K, Miyazaki I, Endou Y, Tanaka M, Sasaki T (1991b) Expression of c-erbB-2 oncoprotein in gastric carcinoma. Cancer 67:2914–2918

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Professor Dr. R. Pichlmayr on the occasion of his 60th birthday

This work was supported by a research fellowship from the Deutsche Forschungsgemeinschaft (Ja 509/2-1) and by a grant from the Wells foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jaehne, J., Urmacher, C., Thaler, H.T. et al. Expression ofHer2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma. J Cancer Res Clin Oncol 118, 474–479 (1992). https://doi.org/10.1007/BF01629433

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01629433

Key words

Navigation